Steffen Zopf
- Immunology top 10%
- Surgery top 10%
- Molecular Biology
- Epidemiology
- Hepatology top 5%
- Co-authors
- Markus F. NeurathMatthias OckerStefan PflanzDavid VoehringerMarcus SchuchmannTamar MchedlidzeAndrew L. RankinStefan Wirtz
- Topics
- Liver Disease Diagnosis and Treatment (15 papers)Histone Deacetylase Inhibitors Research (9 papers)Hepatocellular Carcinoma Treatment and Prognosis (6 papers)
- Cited by
- HepatologyImmunologySurgery
- Journals
- ImmunityGastroenterologyPLoS ONE
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Steffen Zopf
45 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Immunology 335
- Surgery 315
- Molecular Biology 305
- Epidemiology 235
- Hepatology 220
Countries citing papers authored by Steffen Zopf
This map shows the geographic impact of Steffen Zopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Zopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Zopf more than expected).
Fields of papers citing papers by Steffen Zopf
This network shows the impact of papers produced by Steffen Zopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Zopf. The network helps show where Steffen Zopf may publish in the future.
Co-authorship network of co-authors of Steffen Zopf
This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Zopf. A scholar is included among the top collaborators of Steffen Zopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Zopf. Steffen Zopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 35 | |
| 4 | 16 | |
| 5 | 3 | |
| 6 | 41 | |
| 7 | 8 | |
| 8 | 10 | |
| 9 | Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosisbreakdown → | 418 |
| 10 | 4 | |
| 11 | 13 | |
| 12 | 37 | |
| 13 | Antitumoral efficacy of four histone deacetylase inhibitors in hepatoma in vitro and in vivo. | 6 |
| 14 | 29 | |
| 15 | 26 | |
| 16 | 61 | |
| 17 | 58 | |
| 18 | 19 | |
| 19 | 23 | |
| 20 | 12 |
About Steffen Zopf
Steffen Zopf is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 45 papers that have together received 1.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Histone Deacetylase Inhibitors Research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). The work is most often cited by research in Hepatology (220 citations), Immunology (335 citations) and Surgery (315 citations). Steffen Zopf has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Markus F. Neurath, Matthias Ocker, Stefan Pflanz, David Voehringer, Marcus Schuchmann, Tamar Mchedlidze, Andrew L. Rankin, Stefan Wirtz, Jennifer A. Walker and Maximilian J. Waldner. Their work appears in journals such as Immunity, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.